Genomic alterations of KEAP1/NFE2L2/CUL3(K/N/C) in Chinese lung cancer patients (pts)

被引：0
|
作者：
Qian, C. [1 ]
Wang, C. [2 ]
Wang, X. [2 ]
He, Q. [2 ]
Ma, T. [2 ]
Zhang, X. [2 ]
机构：
[1] Peoples Liberat Army Mil Med Univ, Affiliated Hosp 3, Daping Hosp, Dept Oncol, Chongqing, Peoples R China
[2] Genetron Hlth Beijing Co Ltd, Dept Translat Med, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2002P
引用
收藏
页码：S1118 / S1118
页数：1
相关论文
共 50 条
  • [41] NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy
    Xu, Xian
    Yang, Yang
    Liu, Xiaoyan
    Cao, Na
    Zhang, Peng
    Zhao, Songhui
    Chen, Donglin
    Li, Li
    He, Yong
    Dong, Xiaowei
    Wang, Kai
    Lin, Hanqing
    Mao, Naiquan
    Liu, Lingxiang
    ONCOLOGIST, 2020, 25 (06): : E955 - E963
  • [42] Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes
    Wang, Kewei
    Li, Zixi
    Xuan, Ying
    Zhao, Yong
    Deng, Chao
    Wang, Meidan
    Xie, Chenjun
    Yuan, Fenglai
    Pang, Qingfeng
    Mao, Wenjun
    Cai, Dongyan
    Zhong, Zhangfeng
    Mei, Jie
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [43] An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2′-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma
    Hintsala, Hanna-Riikka
    Haapasaari, Kirsi-Maria
    Soini, Ylermi
    Karihtala, Peeter
    HISTOLOGY AND HISTOPATHOLOGY, 2017, 32 (02) : 129 - 136
  • [44] An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes
    Liu, Zongang
    Deng, Meiyan
    Wu, Lin
    Zhang, Suning
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [45] Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes
    Kewei Wang
    Zixi Li
    Ying Xuan
    Yong Zhao
    Chao Deng
    Meidan Wang
    Chenjun Xie
    Fenglai Yuan
    Qingfeng Pang
    Wenjun Mao
    Dongyan Cai
    Zhangfeng Zhong
    Jie Mei
    Cancer Cell International, 23
  • [46] An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes
    Zongang Liu
    Meiyan Deng
    Lin Wu
    Suning Zhang
    Molecular Medicine, 2020, 26
  • [47] Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer
    Thu, Kelsie L.
    Pikor, Larissa A.
    Chari, Raj
    Wilson, Ian M.
    MacAulay, Calum E.
    English, John C.
    Tsao, Ming-Sound
    Gazdar, Adi F.
    Lam, Stephen
    Lam, Wan L.
    Lockwood, William W.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) : 1521 - 1529
  • [48] KEAP1-Mutations and NFE2L2-Mutations in Patients with Non-Small Cell Lung Cancer (NSCLC)
    Frank, Rieke
    Scheffler, Matthias
    Michels, Sebastian
    Eisert, Anna
    Fischer, Rieke N.
    Koenig, Katharina
    Merkelbach-Bruse, Sabine
    Serke, Monika H.
    Ko, Yon-Dschun
    Gerigk, Ulrich
    Geist, Thomas
    Heukamp, Lukas C.
    Buettner, Reinhard
    Wolf, Juergen
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S215 - S215
  • [49] KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC)
    Frank, R.
    Scheffler, M.
    Michels, S.
    Eisert, A.
    Gogl, L.
    Fischer, R.
    Koenig, K.
    Merkelbach-Bruse, S.
    Serke, M.
    Ko, Y. -D
    Gerigk, U.
    Geist, T.
    Heukamp, L.
    Buettner, R.
    Wolf, J.
    Oncology Research and Treatment, 2015, 38 : 268 - 268
  • [50] KEAP1-mutations and NFE2L2-mutations in patients with non-small cell lung cancer (NSCLC)
    Frank, R.
    Scheffler, M.
    Michels, S.
    Eisert, A.
    Fischer, R.
    Koenig, K.
    Merkelbach-Bruse, S.
    Serke, M.
    Ko, Y. D.
    Gerigk, U.
    Geist, T.
    Heukamp, L.
    Buettner, R.
    Wolf, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S645 - S645
12345